Risk factors in using drugs outside of their licence guidelines in paediatric patients
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: CELJO, Vedada (Clinical Centar University of Sarajevo, clinical pharmacy, sarajevo, Bosnia and Herzegovina)
- Co-author(s): Vedada Celjo: clinical pharmacy, Clinical Centar University of Sarajevo, sarajevo, Bosnia and Herzegovina
Nermina Crnkic: Clinical Centar University of Sarajevo, Sarajevo, Bosnia and Herzegovina
A significant number of pharmaceutical products, whether used in paediatric hospitals or prescribed by general practitioners, do not have specific therapeutic purposes for administration in young children and they are usually used outside the guidelines of their manufacturing licence and product information.
The ratio is somewhat.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.